This article was originally published on TipRanks.com Biopharmaceutical company Amgen Inc.
This article was originally published on TipRanks.com Amgen (AMGN) is an American multinational drug company.
This article was originally published on TipRanks.com Amgen (NASDAQ: AMGN), an American multinational biopharmaceutical company, announced that Japan has approved LUMAKRAS (sotorasib), the first-of-its-kind KRAS G12C inhibitor.
This article was originally published on TipRanks.com Amgen (AMGN) is a global biopharmaceutical company based in California.
This article was originally published on TipRanks.com Amgen (AMGN) has raised its quarterly cash dividend by 10% to $1.
This article was originally published on TipRanks.com Amgen (AMGN) has revealed positive topline results from the Phase 3 DISCREET trial.
Amgen, Inc. (AMGN) revealed that it has started construction on its new biomanufacturing plant in Ohio.
Amgen (AMGN) has reported robust third-quarter 2021 results, which surpassed both earnings and revenue estimates. Shares of the biotechnology company, however, slipped 1.